A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19

Administered By

Awarded By

Contributors

Start/End

  • February 21, 2020 - March 31, 2026